122 related articles for article (PubMed ID: 33772822)
1. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Ott CA; Walroth TA; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Jun; 41(6):494-500. PubMed ID: 33772822
[TBL] [Abstract][Full Text] [Related]
2. QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings.
Isbister GK; Brown AL; Gill A; Scott AJ; Calver L; Dunlop AJ
Br J Clin Pharmacol; 2017 Oct; 83(10):2274-2282. PubMed ID: 28488266
[TBL] [Abstract][Full Text] [Related]
3. QTc interval screening in an opioid treatment program.
Katz DF; Sun J; Khatri V; Kao D; Bucher-Bartelson B; Traut C; Lundin-Martinez J; Goodman M; Mehler PS; Krantz MJ
Am J Cardiol; 2013 Oct; 112(7):1013-8. PubMed ID: 23820570
[TBL] [Abstract][Full Text] [Related]
4. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia.
Nagele P; Pal S; Brown F; Blood J; Miller JP; Johnston J
Anesthesiology; 2012 Aug; 117(2):321-8. PubMed ID: 22692379
[TBL] [Abstract][Full Text] [Related]
5. Use of portable single-lead electrocardiogram device as an alternative for QTc monitoring in critically ill patients.
Rebolledo-Del Toro M; Carvajalino-Galeano AB; Pinto-Brito C; Muñoz-Velandia OM; García-Peña ÁA
Ann Noninvasive Electrocardiol; 2024 May; 29(3):e13116. PubMed ID: 38627955
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients.
Zaballos M; Fernández I; Rodríguez L; Orozco S; García A; Juncos M; Alvarez-Zaballos S; Piñeiro P; Hortal J
Sci Rep; 2023 Jul; 13(1):10985. PubMed ID: 37415069
[TBL] [Abstract][Full Text] [Related]
7. Validation of a Handheld 6-Lead Device for QT Interval Monitoring in Resource-Limited Settings.
Metcalfe JZ; Economou T; Naufal F; Kucukosmanoglu M; Kleiman R; Phillips PPJ; Conradie F
JAMA Netw Open; 2024 Jun; 7(6):e2415576. PubMed ID: 38848063
[TBL] [Abstract][Full Text] [Related]
8. Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial.
Wieneke H; Conrads H; Wolstein J; Breuckmann F; Gastpar M; Erbel R; Scherbaum N
Eur J Med Res; 2009 Jan; 14(1):7-12. PubMed ID: 19258204
[TBL] [Abstract][Full Text] [Related]
9. Routine Monitoring of QTc Interval as a Barrier for Efficient Use of Methadone in Palliative Care.
Pawate V; Davila JSA; Reddy A; Bruera E
J Pain Symptom Manage; 2024 Feb; 67(2):e147-e150. PubMed ID: 37863373
[TBL] [Abstract][Full Text] [Related]
10. Effect on QTc interval by switching from methadone to equipotent R-methadone dose in methadone maintenance treatment patients.
Havig SM; Berg-Pedersen RM; Krabseth HM; Müller LD; Haugaa K; Zare HK; Gjesdal K; Krajci P; Opdal MS
Basic Clin Pharmacol Toxicol; 2024 Apr; 134(4):519-530. PubMed ID: 38308508
[TBL] [Abstract][Full Text] [Related]
11. Agreement of Computerized QT and QTc Interval Measurements Between Both Bedside and Expert Nurses Using Electronic Calipers.
Ho K; Ganesh GK; Prasad S; Hoffmann TJ; Larsen A; Sandoval C; Berger S; Schell-Chaple H; Badilini F; Mackin LA; Pelter MM
J Cardiovasc Nurs; 2023 Oct; ():. PubMed ID: 37787695
[TBL] [Abstract][Full Text] [Related]
12. Gefitinib Increases the Incidence of QT Prolongation in Patients with Non-Small Cell Lung Cancer.
Maimaitituersun G; Abulimiti B; Jin M; Dong X; Fu Z
Int Heart J; 2023; 64(3):365-373. PubMed ID: 37258113
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study.
Schmittner J; Schroeder JR; Epstein DH; Krantz MJ; Eid NC; Preston KL
Pharmacotherapy; 2009 May; 29(5):495-502. PubMed ID: 19397459
[TBL] [Abstract][Full Text] [Related]
14. Manual vs. automatic assessment of the QT-interval and corrected QT.
Neumann B; Vink AS; Hermans BJM; Lieve KVV; Cömert D; Beckmann BM; Clur SB; Blom NA; Delhaas T; Wilde AAM; Kääb S; Postema PG; Sinner MF
Europace; 2023 Aug; 25(9):. PubMed ID: 37470430
[TBL] [Abstract][Full Text] [Related]
15. Serial electrocardiogram recordings revealed a high prevalence of QT interval prolongation in patients with tuberculosis receiving fluoroquinolones.
Ju KS; Lee RG; Lin HC; Chen JH; Hsu BF; Wang JY; Van Dong N; Yu MC; Lee CH
J Formos Med Assoc; 2023 Dec; 122(12):1255-1264. PubMed ID: 37268474
[TBL] [Abstract][Full Text] [Related]
16. QTNet: Predicting Drug-Induced QT Prolongation With Artificial Intelligence-Enabled Electrocardiograms.
Zhang H; Tarabanis C; Jethani N; Goldstein M; Smith S; Chinitz L; Ranganath R; Aphinyanaphongs Y; Jankelson L
JACC Clin Electrophysiol; 2024 May; 10(5):956-966. PubMed ID: 38703162
[TBL] [Abstract][Full Text] [Related]
17. QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.
Martin JA; Campbell A; Killip T; Kotz M; Krantz MJ; Kreek MJ; McCarroll BA; Mehta D; Payte JT; Stimmel B; Taylor T; Haigney MC; Wilford BB;
J Addict Dis; 2011 Oct; 30(4):283-306. PubMed ID: 22026519
[TBL] [Abstract][Full Text] [Related]
18. Development of an AI-Driven QT Correction Algorithm for Patients in Atrial Fibrillation.
Tarabanis C; Ronan R; Shokr M; Chinitz L; Jankelson L
JACC Clin Electrophysiol; 2023 Feb; 9(2):246-254. PubMed ID: 36858692
[TBL] [Abstract][Full Text] [Related]
19. Detection of QT interval prolongation using Apple Watch electrocardiogram in children and adolescents with congenital long QT syndrome.
Yee-Ming Li J; Kwok SY; Tsao S; Hoi-Yan Chung C; Hing-Sang Wong W; Cheung YF
Int J Cardiol Heart Vasc; 2023 Aug; 47():101232. PubMed ID: 37346232
[TBL] [Abstract][Full Text] [Related]
20. AI-Assisted QT Measurements for Highly Automated Drug Safety Studies.
Diaw MD; Papelier S; Durand-Salmon A; Felblinger J; Oster J
IEEE Trans Biomed Eng; 2023 May; 70(5):1504-1515. PubMed ID: 36355743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
